1. Greenblatt, DJ, Koch-Weser, J: Drug Therapy. Clinical pharmacokinetics. (First of two parts),N Engl J Med, 293: 702, 1975.

   Article PubMed CAS  Google Scholar 

2. Greenblatt, DJ, Koch-Weser, J: Drug Therapy. Clinical pharmacokinetics. (Second of two parts).N Engl J Med, 293: 964, 1975.

   Article PubMed CAS  Google Scholar 

3. Goldzieher, JW, Dozier, TS and de la Pena, A: Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol.Contraception, 21: 1, 1980.

   Article PubMed CAS  Google Scholar 

4. Stanczyk, FZ, Mroszczaka, EJ, Ling, T, Runkel, R, Henzl, M, Miyakawa, I, Goebelsmann, U: Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women. Contraception, in press.

   Article  Google Scholar 

5. Gibaldi, M and Perrier, D:Pharmacokinetics. New York and Basel, Marcel Dekker, Inc. 1982.

   Google Scholar 

6. Stanczyk, FZ, Gale, JA, Goebelsmann, U, Nerenberg, C, Matin, S: Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone.Contraception, 22: 457, 1980.

   Article PubMed CAS  Google Scholar 

7. Cook CE, Tallent, CR and Christensen, HD: Antigens from synthetic and natural estrogens: formation by conjugation with protein through a thiopropionic acid line.Life Sci, 14: 1075, 1974.

   Article PubMed CAS  Google Scholar 

8. Fotherby, K et al. (WHO Collaborative Study). Pharmacokinetics of ethinyloestradiol in women from different populations.Contraception, 23: 487, 1981.

   Article PubMed CAS  Google Scholar 

9. Metzler, CM, Elfring, GL, McEwen, JM: A user’s manual for NONLIN and associated program. Research Biostatistics. The Upjohn Company, Kalamazoo, Michigan, April 20, 1974.

   Google Scholar 

10. Back, DJ, Breckenridge, AM, Crawford, FE, Maclver, M, Orme, ML’E, Rowe, PH and Watts, MJ: An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.Contraception, 20: 263, 1979.

    Article PubMed CAS  Google Scholar 

11. Back, DJ, Bates, M, Breckenridge, AM, Hall, JM, Maclver, M, Orme, ML’E, Park, BK and Rowe, PH: The pharmacokinetics of levonorgestrel and ethinylestradiol in women — studies with Ovran and Ovranette.Contraception, 23: 229, 1981.

    Article PubMed CAS  Google Scholar 

12. Humpel, M, Nieuweboer, B, Wendt, H and Speck, U: Investigations of Pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women.Contraception, 19: 421, 1979.

    Article PubMed CAS  Google Scholar 

13. Warren, RJ and Fotherby, K: Plasma levels of ethynyloestradiol after administration of ethynyloestradiol or mestranol to human subjects.J Endocrinol, 59: 369, 1973.

    Article PubMed CAS  Google Scholar 

14. Helton, ED and Goldzieher, JW: The pharmacokinetics of ethynyl estrogens. A review.Contraception, 15: 255, 1977.

    Article PubMed CAS  Google Scholar 

15. Bird, CE, Clark, AF: Metabolic clearance rates and metabolism of mestranol and ethynylestradiol in normal young women.J Clin Endocrinol Metab, 36: 296, 1973.

    Article PubMed CAS  Google Scholar 

16. Mills, TM, Lin, TJ, Hernandez-Ayup, S, Greenblatt, RB, Ellegood, JO, Mahesh, VB: The metabolic clearance rate and urinary excretion of oral contraceptive drugs. II. Mestranol.Am J Obstet Gynecol, 120: 773, 1974.

    CAS  Google Scholar 

17. Fotherby, K, et al: (WHO Collaborative Study). Rate of metabolism of norethisterone in women from different populations.Contraception, 19: 39, 1979.

    Article PubMed CAS  Google Scholar 

18. Back, DJ, Breckenridge, AM, Crawford, FE, Mclver, M, Orme, ML’E, Rowe, PH, Smith, E: Kinetics of norethindrone in women. II. Single-dose kinetics.Clin Pharmacol Ther, 24: 448, 1978.

    PubMed CAS  Google Scholar 

19. Mills, TM, Lin, TJ, Hernandez-Ayup, S, Greenblatt, RB, Ellegood, JO, Mahesh, VB: The metabolic clearance rate and urinary excretion of oral contraceptive drugs. I. Norethindrone.Am J Obstet Gynecol, 120: 764, 1974.

    CAS  Google Scholar 

20. Humpel, M, Wendt, H, Dogs, G, Weiss, Chr, Rietz, S, Speck, U: Intraindividual comparison of pharmacokinetic parameters of d-norgestrel, lynestrenol and cyproterone acetate in 6 women.Contraception, 16: 199, 1977.

    Article  Google Scholar 

21. Humpel, M, Wendt, H, Pommerenke, G, Weiss, Chr, Speck, U: Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.Contraception, 17: 207, 1978.

    Article PubMed CAS  Google Scholar 

22. Kiriwat, O, Fotherby, K: Pharmacokinetics of oral contraceptive steroids after morning and evening administration.Contraception, 27: 153, 1983.

    Article PubMed CAS  Google Scholar 

23. Brenner, PF, Mishell, DR, Jr, Stanczyk, FZ, Goebelsmann, U: Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.Am J Obstet Gynecol, 129: 133, 1977.

    PubMed CAS  Google Scholar 

24. Weiner, E, Victor, A, Johansson, EDB: Plasma levels of d-norgestrel after oral administration.Contraception, 14: 563, 1976.

    Article PubMed CAS  Google Scholar 

25. Back, DJ, Breckenridge, AM, Crawford, FE, Mclver, M, Orme, ML’E, Park, BK, Rowe, PH, Smith, E: Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosing. Clin Pharmacol Ther, 24: 439, 1978.

    PubMed CAS  Google Scholar 

26. Odlind, V, Victor, A, Johansson, EDB: Plasma protein binding of norethisterone.Contraception, 25: 457, 1982.

    Article PubMed CAS  Google Scholar 

27. Victor, A, Weiner, E, Johansson, EDB: Sex hormone binding globulin: the carrier protein for d-norgestrel.J Clin Endocrinol Metab, 43: 244, 1976.

    Article PubMed CAS  Google Scholar 

28. Jenkins, N, Fotherby, K: Binding of the contraceptive steroids norgestrel and norethisterone in human plasma.J Steroid Biochem, 13: 521, 1980.

    Article PubMed CAS  Google Scholar 

29. Pardridge, WM: Transport of protein-bound hormones into tissues in vivo. Endocrine Reviews, 2: 103, 1981.

    Article PubMed CAS  Google Scholar 

30. Reed, MJ, Fotherby, K: Interaction of ethynyloestradiol sulphate with plasma proteins.J Steroid Biochem, 13: 495, 1980.

    Article PubMed CAS  Google Scholar 

31. Jenkins, N, Fotherby, K: Binding of the gestagens norethisterone and levonorgestrel in blood of various species.J Steroid Biochem, 14: 1055, 1981.

    Article PubMed CAS  Google Scholar 

32. Prasad, KVS, Narasinga Rao, BS, Sivakumar, B, Prema, K: Pharmacokinetics of norethindrone in Indian women.Contraception, 20: 77, 1979.

    Article PubMed CAS  Google Scholar 

33. Kirton, KT, Cornette, JC: Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera™).Contraception, 10: 39, 1974.

    Article PubMed CAS  Google Scholar 

34. Jeppsson, S, Johansson, EDB: Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of DepoProvera to women.Contraception, 14: 461, 1976.

    Article PubMed CAS  Google Scholar 

35. Ortiz, A, Hiroi, M, Stanczyk, FZ, Goebelsmann, U, Mishell, DR, Jr: Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.J Clin Endocrinol Metab, 44: 32, 1977.

    Article PubMed CAS  Google Scholar 

36. Hiroi, M, Stanczyk, FZ, Goebelsmann, U, Brenner, PF, Lumkin, ME, Mishell, DR, Jr: Radioimmunoassay of serum medroxyprogesterone acetate (Provera™) in women following oral and intravaginal administration.Steroids, 26: 373, 1975.

    Article PubMed CAS  Google Scholar 

37. Fotherby, K, Koetsawang, S, Mathrubutham, M: Pharmacokinetic study of different doses of Depo-Provera.Contraception, 22: 527, 1980.

    Article PubMed CAS  Google Scholar 

38. Gerhards, E, Hecker, W, Bellmann, 0: Studies on the kinetics and metabolism of 17β-heptanoyl-17α-ethinyl-4-oestren-3-one-73H norethisterone enanthate in humans following intramuscular injection.Arzneim-Forsch (Drug Res), 26: 1611, 1976.

    CAS  Google Scholar 

39. Saxena, BN, Shrimanker, K, Fotherby, K: Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration.J Steroid Biochem, 8: 1117, 1977.

    Article PubMed CAS  Google Scholar 

40. Sang, GW, Fotherby, F, Howard, G, Elder, M, Bye, PG: Pharmacokinetics of norethisterone oenanthate in humans.Contraception, 24: 15, 1981.

    Article PubMed CAS  Google Scholar 

41. Weiner, E, Johansson, EDB: Plasma levels of norethindrone after I.M. injection of 200 mg of norethindrone enanthate.Contraception, 11: 419, 1975.

    Article PubMed CAS  Google Scholar 

42. Howard, G, Warren, RJ, Fotherby, K: Plasma levels of norethisterone in women receiving norethisterone oenanthate intramuscularly.Contraception, 12: 45, 1975.

    Article PubMed CAS  Google Scholar 

43. Fotherby, K, Howard, G, Shrimanker, K, Elder, M, Bye, PG: Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate.Contraception, 18: 1, 1978.

    Article PubMed CAS  Google Scholar 

44. Goebelsmann, U, Stanczyk, FZ, Brenner, PF, Goebelsmann, AE, Gentzschein, EK, Mishell, DR, Jr: Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.Contraception, 19: 283, 1979.

    Article PubMed CAS  Google Scholar 

45. Prasad, KVS, Madhavan Nair, K, Sivakumar, B, Prema, K, Narasinga Rao, BS: Plasma levels of norethindrone in Indian women receiving norethindrone enanthate (20 mg) injectable.Contraception, 23: 497, 1981.

    Article PubMed CAS  Google Scholar 

46. Fotherby, K, Howard, G, Shrimanker, K, Elder, M, Bye, PG: Effect of norethisterone oenanthate on serum gonadotropin levels.Contraception 16: 591, 1977.

    Article PubMed CAS  Google Scholar 

47. Back, DJ, Breckenridge, AM, Chapman, CR, Crawford, FE, Elsen, KA, Orme, ML’E, Rowe, PH: Studies on the enzymatic cleavage of norethisterone oenanthate.Contraception, 23: 125, 1981.

    Article PubMed CAS  Google Scholar 

48. Weiner, E, Johansson, EDB: Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel.Contraception, 14: 81, 1976.

    Article PubMed CAS  Google Scholar 

49. Moore, DE, Roy, S, Stanfzyk, FZ, Mishell, DR, Jr: Bleeding and serum d-norgestrel subdermal polysiloxane capsules for contraception.Contraception, 23: 197, 1981.

    Article  Google Scholar 

50. Croxatto, HB, Diaz, S, Miranda, P, Elamsson, K, Johansson, EDB: Plasma levels of levonorgestrel in women during long term use of norplant.Contraception, 23: 197, 1981.

    Article PubMed CAS  Google Scholar 

51. Alvarez, F, Brache, V, Faundes, A, Johansson, EDB, Odlind, V, Nash, H: Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.Contraception, 27: 123, 1983.

    Article PubMed CAS  Google Scholar 

52. Laumas, V, Jain, AK, Jha, P, Rahman, SA, Jumar, D, Malik, BK, Sarkar, NN, Takkar, D, Hingorani, V, Laumas, KR: Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.Contraception, 23: 211, 1981.

    Article PubMed CAS  Google Scholar 

53. Mishell, DR, Jr, Lumkin, ME, Jackanicz, T: Initial clinical studies of intravaginal rings containing norethindrone and norgestrel.Contraception, 12: 253, 1975.

    Article PubMed  Google Scholar 

54. Stanczyk, FZ, Hiroi, M, Goebelsmann, U, Brenner, PF, Lumkin, ME, Mishell, DR, Jr: Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration.Contraception, 12: 279, 1975.

    Article PubMed CAS  Google Scholar 

55. Victor, A, Edqvist, LE, Lindberg, P, Elamsson, K, Johansson, EDB: Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings implanted with dl-norgestrel.Contraception, 12: 261, 1975.

    Article PubMed CAS  Google Scholar 

56. Jackanicz, TM: Levonorgestrel and estradiol release from an improved contraceptive vaginal ring.Contraception, 24: 323, 1981.

    Article PubMed CAS  Google Scholar 

57. Landgren, B-M, Johannisson, E, Masironi, B, Diczfalusy, E: Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.Contraception, 26: 567, 1982.

    Article PubMed CAS  Google Scholar 

58. Burton, FG, Skiens, WE, Gordon, NR, Veal, JT, Kalkwarf, DR, Duncan, GW: Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroids.Contraception, 17: 221 1978.

    Article PubMed CAS  Google Scholar 

59. Landgren, B-M, Oriowo, MA, Diczfalusy, E: Pharmacokinetic and pharmacodynamic studies with vaginal devices releasing norethisterone at a constant near zero order.Contraception, 24: 29, 1981.

    Article PubMed CAS  Google Scholar 

60. Rigg, LA, Milanes, B, Villanueva, B, Yen, SSC: Efficacy of intravaginal and intranasal administration of micronized estradiol-17β.J Clinical Endocrinol Metab, 45: 1261, 1977.

    Article CAS  Google Scholar 

61. Yen, SSC, Martin, PL, Burnier, AM, Czekala, NM, Greaney, MO, Jr, Callantine, M: Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women.J Clin Endocrinol Metab, 40: 518, 1975.

    Article PubMed CAS  Google Scholar 

62. Mandel, FP, Geola, FL, Lu, JKH, Eggena, P, Sambhi, MP, Hershman, JM, Judd, HL: Biologic effects of various doses of ethinyl estradiol in postmenopausal women.Obstet Gynecol, 59: 673, 1982.

    PubMed CAS  Google Scholar 

63. Mashchak, CA, Mishell, DR, Jr, Goebelsmann, U: Comparison of hepatic alterations produced by oral and vaginal administration of ethinyl- estradiol. J Clin Endocrinol Metab, in press.

    Google Scholar 

64. Mashchak, CA, Lobo, RA, Dozona-Takano, R, Eggena, P, Nakamura, RM, Brenner, PF, Mishell, DR, Jr: Comparison of pharmacodynamic properties of various estrogen formulations.Am J Obstet Gynecol, 144: 511, 1982.

    PubMed CAS  Google Scholar 

65. Schwartz, U, Schneller, E, Moltz, L, Hammerstein, J: Vaginal administration of ethinylestradiol: effects on ovulation and hepatic transcortin synthesis.Contraception, 25: 253, 1982.

    Article PubMed CAS  Google Scholar 

Download references